ETOSHIA RENEE JACKSON

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family MEMPHIS, TN NPI 1982248779

General Payments — all program years on this page

$661.91

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 25
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $439.57 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $439.5719

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $137.476
DEXCOM, INC. $111.592
Dynavax Technologies Corporation $98.626
Lilly USA, LLC $30.412
Biogen, Inc. $27.531
Organon LLC $20.001
Merck Sharp & Dohme Corporation $13.951

By program year

Program yearAmountRecords
2021 $128.932
2022 $25.671
2023 $67.743
2024 $439.5719

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082146693 Dynavax Technologies Corporation $18.69 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082147915 Dynavax Technologies Corporation $8.32 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082148937 Dynavax Technologies Corporation $27.49 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082152301 Dynavax Technologies Corporation $22.21 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082153113 Dynavax Technologies Corporation $20.63 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1082153137 Dynavax Technologies Corporation $1.28 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100240719 Novo Nordisk Inc $23.96 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100314529 Novo Nordisk Inc $22.87 03/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100347914 Novo Nordisk Inc $16.91 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100395832 Novo Nordisk Inc $24.88 08/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100456744 Novo Nordisk Inc $23.97 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100584260 Novo Nordisk Inc $24.88 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104866556 Biogen, Inc. $27.53 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135667858 Lilly USA, LLC $16.73 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135677979 Lilly USA, LLC $13.68 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1136189430 Organon Llc $20.00 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141770010 Merck Sharp & Dohme LLC $13.95 06/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153360941 Dexcom, Inc. $15.04 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153360943 Dexcom, Inc. $96.55 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.